In a recent @CellReports study, #TUS scientists reveal the dendritic cell immunoreceptor protein as a novel therapeutic target for treating #colitis and #colorectaltumor in patients with #IntestinalInflammation.
Read more: https://t.co/mqphdHqMSl pic.twitter.com/C3um6FKsaM
— Tokyo University of Science (TUS) (@TUS_PR_en) August 4, 2022
:::